500
Participants
Start Date
January 1, 2018
Primary Completion Date
May 31, 2025
Study Completion Date
December 31, 2025
Lacosamide
Patients with autoimmune related epilepsy were included. After obtaining informed consent, lacosamide was given according to the weight of the patients, and the efficacy and safety were observed.
XijingH, Xi'an
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Second Affiliated Hospital of Xi'an Jiaotong University
OTHER
Xian Children's Hospital
OTHER_GOV
Baoji Central Hospital
OTHER
First Affiliated Hospital of Kunming Medical University
OTHER
First Affiliated Hospital of Harbin Medical University
OTHER
Qilu Children's Hospital of Shandong University
OTHER
Liu Yonghong
OTHER